{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:34:34Z","timestamp":1786988074570,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7252200"],"award-info":[{"award-number":["7252200"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173710"],"award-info":[{"award-number":["82173710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-1\\u2013028"],"award-info":[{"award-number":["2021-I2M-1\\u2013028"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejmech.2025.118438","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:17:17Z","timestamp":1764721037000},"page":"118438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design, synthesis, and neuroprotective evaluation of chiral butylphthalide-ligustrazine hybrids via the Keap1-Nrf2 pathway in ischemic stroke"],"prefix":"10.1016","volume":"303","author":[{"given":"Chenwei","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haochen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanxing","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-1456","authenticated-orcid":false,"given":"Yu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118438_bib1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.amjmed.2021.07.027","article-title":"Ischemic stroke","volume":"134","author":"Feske","year":"2021","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2025.118438_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"20","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.118438_bib3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1161\/01.STR.32.8.1732","article-title":"Incidence of the major stroke subtypes: initial findings from the North East Melbourne stroke incidence study (NEMESIS)","volume":"32","author":"Thrift","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ejmech.2025.118438_bib4","article-title":"Stroke in the 21(st) century: a snapshot of the burden, epidemiology, and quality of life","volume":"2018","author":"Donkor","year":"2018","journal-title":"Stroke Res. Treat."},{"key":"10.1016\/j.ejmech.2025.118438_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00709-019-01439-2","article-title":"Ischemic stroke and mitochondria: mechanisms and targets","volume":"257","author":"Andrabi","year":"2020","journal-title":"Protoplasma"},{"key":"10.1016\/j.ejmech.2025.118438_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.14336\/AD.2017.1126","article-title":"Mitochondria in ischemic stroke: New insight and implications","volume":"9","author":"Liu","year":"2018","journal-title":"Aging Dis"},{"key":"10.1016\/j.ejmech.2025.118438_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mito.2022.01.001","article-title":"Mitochondrial repair as potential pharmacological target in cerebral ischemia","volume":"63","author":"Kaur","year":"2022","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ejmech.2025.118438_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030305","article-title":"Understanding the pathophysiology of ischemic stroke: the basis of current therapies and opportunity for new ones","volume":"14","author":"Salaudeen","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2025.118438_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","article-title":"Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications","volume":"42","author":"Tuo","year":"2022","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118438_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41392-022-01064-1","article-title":"Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejmech.2025.118438_bib11","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/S0140-6736(08)60694-7","article-title":"Stroke","volume":"371","author":"Donnan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.118438_bib12","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.118438_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249382","article-title":"Modulatory effect of myokines on reactive oxygen species in Ischemia\/Reperfusion","volume":"21","author":"Szab\u00f3","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118438_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10030574","article-title":"Oxidative stress in Ischemia\/Reperfusion injuries following acute ischemic stroke","volume":"10","author":"Jurcau","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2025.118438_bib15","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.2174\/1381612826666200708133912","article-title":"Pathophysiology of ischemic stroke: role of oxidative stress","volume":"26","author":"Orellana-Urz\u00faa","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2025.118438_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123045","article-title":"Research progress of traditional Chinese medicine in the treatment of ischemic stroke by regulating mitochondrial dysfunction","volume":"357","author":"Wang","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2025.118438_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101883","article-title":"Mitochondrial mechanisms in cerebral Ischemia-Reperfusion Injury: unravelling the intricacies","volume":"77","author":"Kumar Saini","year":"2024","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ejmech.2025.118438_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12035-012-8344-z","article-title":"Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation","volume":"47","author":"Sanderson","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.118438_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.118438_bib20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2025.118438_bib21","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1007\/s12035-020-02049-3","article-title":"Activation of p62-Keap1-Nrf2 pathway protects 6-Hydroxydopamine-Induced ferroptosis in dopaminergic cells","volume":"57","author":"Sun","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.118438_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11122377","article-title":"Nrf2 regulates oxidative stress and its role in cerebral ischemic stroke","volume":"11","author":"Wang","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2025.118438_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/med.21925","article-title":"KEAP1-NRF2 protein-protein interaction inhibitors: design, pharmacological properties and therapeutic potential","volume":"43","author":"Crisman","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118438_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118438_bib25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2174\/1570159X21666221129100308","article-title":"The role of Nrf2 in relieving cerebral ischemia-reperfusion injury","volume":"21","author":"Sun","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2025.118438_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.phrs.2018.08.007","article-title":"From stroke to neurodegenerative diseases: the multi-target neuroprotective effects of 3-n-butylphthalide and its derivatives","volume":"135","author":"Huang","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118438_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5012341","article-title":"A review of recent advances in neuroprotective potential of 3-N-Butylphthalide and its derivatives","volume":"2016","author":"Abdoulaye","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejmech.2025.118438_bib28","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.2147\/DDDT.S189472","article-title":"3-n-butylphthalide exerts neuroprotective effects by enhancing anti-oxidation and attenuating mitochondrial dysfunction in an in vitro model of ischemic stroke","volume":"12","author":"Chen","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.ejmech.2025.118438_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1542296","article-title":"Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2\/Keap1 complex formation","volume":"16","author":"Yan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118438_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106164","article-title":"DL-3-n-butylphthalide prevents oxidative stress and atherosclerosis by targeting Keap-1 and inhibiting Keap-1\/Nrf-2 interaction","volume":"172","author":"Han","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejmech.2025.118438_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.etap.2015.05.009","article-title":"Effects of N-butylphthalide on the activation of Keap1\/Nrf-2 signal pathway in rats after carbon monoxide poisoning","volume":"40","author":"Li","year":"2015","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118438_bib32","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1080\/10717544.2021.2000678","article-title":"Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy","volume":"28","author":"Zhang","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejmech.2025.118438_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1142\/S0192415X19500265","article-title":"A systematic review of neuroprotective efficacy and safety of DL-3-N-Butylphthalide in ischemic stroke","volume":"47","author":"Xu","year":"2019","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.ejmech.2025.118438_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/med.22009","article-title":"Drugs\/agents for the treatment of ischemic stroke: advances and perspectives","volume":"44","author":"Jia","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2025.118438_bib35","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.ejmech.2010.01.036","article-title":"Synthesis and biological activity of n-butylphthalide derivatives","volume":"45","author":"Wang","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118438_bib36","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.bmcl.2015.06.090","article-title":"Novel hybrids of 3-n-butylphthalide and edaravone: design, synthesis and evaluations as potential anti-ischemic stroke agents","volume":"25","author":"Sheng","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.ejmech.2025.118438_bib37","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1039\/c1ob05478c","article-title":"Design, synthesis and evaluation of nitric oxide releasing derivatives of 3-n-butylphthalide as antiplatelet and antithrombotic agents","volume":"9","author":"Wang","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2025.118438_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116891","article-title":"Synthesis and biological evaluation of hybrids from optically active ring-opened 3-N-butylphthalide derivatives and 4-fluro-edaravone as potential anti-acute ischemic stroke agents","volume":"69","author":"Jia","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118438_bib39","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00005344-200406000-00018","article-title":"Antiplatelet and antithrombotic activity of L-3-n-butylphthalide in rats","volume":"43","author":"Peng","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118438_bib40","doi-asserted-by":"crossref","first-page":"12485","DOI":"10.1021\/acs.jmedchem.0c00887","article-title":"From seeds of Apium graveolens Linn. to a cerebral ischemia medicine: the long journey of 3-n-Butylphthalide","volume":"63","author":"Marco-Contelles","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118438_bib41","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.106.118760","article-title":"l-3-n-Butylphthalide improves cognitive impairment induced by chronic cerebral hypoperfusion in rats","volume":"321","author":"Peng","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejmech.2025.118438_bib42","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4103\/1673-5374.156991","article-title":"Ligustrazine monomer against cerebral ischemia\/reperfusion injury","volume":"10","author":"Gao","year":"2015","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2025.118438_bib43","article-title":"Tetramethylpyrazine enhances neuroprotection and plasticity in cerebral ischemia-reperfusion injury via RhoA\/ROCK2 pathway inhibition","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118438_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114468","article-title":"Tetramethylpyrazine alleviates mitochondrial abnormality in models of cerebral ischemia and oxygen\/glucose deprivation reoxygenation","volume":"367","author":"Chang","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejmech.2025.118438_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108656","article-title":"Bibliometric analysis of research progress on tetramethylpyrazine and its effects on ischemia-reperfusion injury","volume":"259","author":"Qi","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2025.118438_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106961","article-title":"Design, synthesis, and evaluation of n-butylphthalide and ligustrazine hybrids as potent neuroprotective agents for the treatment of ischemic stroke in vitro and in vivo","volume":"142","author":"Jia","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118438_bib47","first-page":"633","article-title":"Design, synthesis, and biological evaluation of ligustrazine\/resveratrol hybrids as potential anti-ischemic stroke agents","volume":"18","author":"Zhang","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118438_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103835","article-title":"N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity","volume":"86","author":"Li","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2025.118438_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/01616412.1997.11740874","article-title":"Monofilament intraluminal middle cerebral artery occlusion in the mouse","volume":"19","author":"Clark","year":"1997","journal-title":"Neurol. Res."},{"key":"10.1016\/j.ejmech.2025.118438_bib50","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s12035-022-03200-y","article-title":"An updated review of mitochondrial transplantation as a potential therapeutic strategy against cerebral ischemia and cerebral Ischemia\/Reperfusion Injury","volume":"60","author":"Huang","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2025.118438_bib51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2022.02.036","article-title":"Advanced drug delivery system against ischemic stroke","volume":"344","author":"Zhang","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ejmech.2025.118438_bib52","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118438_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1124\/dmd.112.049254","article-title":"Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate","volume":"41","author":"Li","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejmech.2025.118438_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020180","article-title":"Increasing brain permeability of PHA-767491, a cell division cycle 7 kinase inhibitor, with biodegradable polymeric nanoparticles","volume":"13","author":"Rojas-Prats","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2025.118438_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082823","article-title":"Moderate hypoxia followed by reoxygenation results in blood-brain barrier breakdown via oxidative stress-dependent tight-junction protein disruption","volume":"8","author":"Zehendner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2025.118438_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116186","article-title":"The role of oxidative stress in blood-brain barrier disruption during ischemic stroke: antioxidants in clinical trials","volume":"228","author":"Lochhead","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118438_bib57","doi-asserted-by":"crossref","first-page":"W463","DOI":"10.1093\/nar\/gkaf361","article-title":"Plip 2025: introducing protein-protein interactions to the protein-ligand interaction profiler","volume":"53","author":"Schake","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2025.118438_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156736","article-title":"Formononetin attenuates myocardial ischemia\/reperfusion injury by regulating neutrophil extracellular traps formation and platelet activation via platelet CD36","volume":"141","author":"Tang","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2025.118438_bib59","article-title":"Neutrophil mobilization triggers microglial functional change to exacerbate cerebral ischemia-reperfusion injury","author":"Jin","year":"2025","journal-title":"Adv. Sci. (Weinh.)"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425012036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:49:54Z","timestamp":1781326194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425012036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":59,"alternative-id":["S0223523425012036"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118438","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and neuroprotective evaluation of chiral butylphthalide-ligustrazine hybrids via the Keap1-Nrf2 pathway in ischemic stroke","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118438"}}